Increasing the number of prostate biopsy cores taken does not improve diagnostic accuracy. Instead, urologists need to think in three dimensions and use template guidance to improve cancer detection and characterization.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies
Theoretical Biology and Medical Modelling Open Access 17 June 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Delongchamps, N. B., de la Roza, G., Jones, R., Jumbelic, M. & Haas, G. P. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int. 103, 49–54 (2009).
Anast, J. W., Andriole, G. L., Bismar, T. A., Yan, Y. & Humphrey, P. A. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Urology 64, 544–550 (2004).
Remzi, M. et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J. Urol. 174, 1256–1261 (2005).
Boccon-Gibod, L. M., Delongchamps, N. B., Toublanc, M., Boccon-Gibod, L. A. & Ravery, V. Prostate saturation biopsy in the re-evaluation of microfocal prostate cancer. J. Urol. 176, 961–964 (2006).
Barzell, W. E. & Melamed, M. R. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience. Urology 70 (6 Suppl.), 27–35 (2007).
Taneja, S. S. Prostate biopsy: targeting cancer for detection and therapy. Rev. Urol. 8, 173–182 (2006).
Andriole, G. L. et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 70 (6 Suppl.), 22–26 (2007).
Megwalu, I. I. et al. Evaluation of a novel precision template-guided biopsy system for detection of prostate cancer. BJU Int. 102, 546–550 (2008).
Mazaheri, Y. et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging—correlation with pathologic findings. Radiology 246, 380–388 (2008).
Jackson, A. S. N. et al. Dynamic contrast-enhanced MRI for prostate cancer localization. Br. J. Radiol. 82, 148–156 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
G. L. Andriole has declared that he is a Stockholder/Director of Envisioneering Medical Technologies, manufacturers of the TargetScan® targeted biopsy system.
Rights and permissions
About this article
Cite this article
Andriole, G. The lottery of conventional prostate biopsy. Nat Rev Urol 6, 188–189 (2009). https://doi.org/10.1038/nrurol.2009.46
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2009.46
This article is cited by
-
Likelihood of sampling prostate cancer at systematic biopsy as a function of gland volume and number of cores
Prostate Cancer and Prostatic Diseases (2024)
-
Der lange Weg von der Palpation zur Biopsie
Der Urologe (2021)
-
Die Prostatabiopsie – eine unendliche Geschichte
Der Pathologe (2012)
-
Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies
Theoretical Biology and Medical Modelling (2010)
